FOXP3 and hepatocellular carcinoma: Similarly, Huang et al. performed a meta-analysis evaluating the relevance of foxP3 plus T cells on GI cancers and demonstrated that a foxP3 plus T cell population is associated with reduced survival and increased recurrence in HCC patients [98].